Australian Pharmaceutical Industries Ltd (API.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 04-2005 | 04-2004 | 04-2003 | 04-2002 | 04-2001 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 2,257 | -13,684 | -25,556 | -3,689 | -4,389 |
| Net Acquisitions | -11,261 | N/A | -9,778 | -12,872 | -3,180 |
| Purchase Of Investment | -24 | N/A | -10,577 | -20,939 | -12,065 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 3,000 |
| Purchase Sale Intangibles | N/A | -253 | N/A | N/A | -500 |
| Other Investing Activity | -6,977 | 0 | 141,678 | 37,500 | -8,826 |
| Investing Cash Flow | $-16,005 | $-13,937 | $95,767 | $N/A | $-25,960 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 54,414 | 7 | 48,000 | 30,000 |
| Debt Repayment | -60,487 | -184 | -107,907 | -13 | -184 |
| Common Stock Issued | 656 | 76 | 2,012 | N/A | N/A |
| Common Stock Repurchased | N/A | -8,753 | N/A | N/A | N/A |
| Dividend Paid | -31,194 | -29,353 | -27,494 | -24,554 | -53,128 |
| Other Financing Activity | -822 | -840 | 0 | 0 | 0 |
| Financing Cash Flow | $-91,847 | $15,360 | $-133,382 | $23,433 | $-23,312 |
| Exchange Rate Effect | 543 | 176 | 61 | N/A | N/A |
| Beginning Cash Position | -74 | 18,893 | 5,742 | 10,050 | 24,729 |
| End Cash Position | 20,080 | -74 | 18,892 | 5,742 | 10,050 |
| Net Cash Flow | $19,611 | $-19,143 | $13,089 | $-4,308 | $-14,679 |
| Free Cash Flow | |||||
| Capital Expenditure | -9,398 | -15,513 | -27,251 | -3,932 | -5,297 |
| Free Cash Flow | -9,398 | -15,513 | -27,251 | -3,932 | -5,297 |